"Mesna" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A sulfhydryl compound used to prevent urothelial toxicity by inactivating metabolites from ANTINEOPLASTIC AGENTS, such as IFOSFAMIDE or CYCLOPHOSPHAMIDE.
| Descriptor ID |
D015080
|
| MeSH Number(s) |
D02.455.326.146.100.050.490 D02.886.489.590 D02.886.645.600.055.050.500
|
| Concept/Terms |
Mesna- Mesna
- Sodium 2-Mercaptoethanesulphonate
- 2-Mercaptoethanesulphonate, Sodium
|
Below are MeSH descriptors whose meaning is more general than "Mesna".
Below are MeSH descriptors whose meaning is more specific than "Mesna".
This graph shows the total number of publications written about "Mesna" by people in this website by year, and whether "Mesna" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mesna" by people in Profiles.
-
Mediastinal sarcoma with deviated tracheal anatomy. J Thorac Oncol. 2008 Jan; 3(1):82-3.
-
[A case of secondary malignant lymphoma of the urinary bladder]. Hinyokika Kiyo. 2006 Apr; 52(4):285-7.
-
Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma. J Clin Oncol. 2004 Dec 15; 22(24):4881-7.
-
Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck. Cancer. 2002 Jul 15; 95(2):322-30.
-
Radiation therapy after a partial response to CHOP chemotherapy for aggressive lymphomas. Int J Radiat Oncol Biol Phys. 2001 Jul 01; 50(3):743-9.
-
High-dose ifosfamide and etoposide with filgrastim for stem cell mobilization in patients with advanced ovarian cancer. Bone Marrow Transplant. 2000 Jun; 25(11):1137-40.
-
Phase II study of paclitaxel in combination with mitoxantrone and ifosfamide/mesna for patients with relapsed or refractory non-Hodgkin's lymphoma after failure to cytarabine/cisplatin combination. Invest New Drugs. 1999; 17(2):187-92.
-
Ninety-six-hour paclitaxel infusion with mitoxantrone and ifosfamide/mesna and consolidation with ESHAP for refractory and relapsed non-Hodgkin's lymphoma. Leuk Lymphoma. 1998 Dec; 32(1-2):97-106.
-
Phase II study of ifosfamide and mesna in patients with metastatic breast cancer. Am J Clin Oncol. 1998 Aug; 21(4):413-5.
-
Alternating triple therapy for the treatment of intermediate grade and immunoblastic lymphoma. Ann Oncol. 1998 May; 9(5):511-8.